"10.1371_journal.pone.0072156","plos one","2013-08-19T00:00:00Z","Fabian Richter; Timo Liebig; Eric Guenzi; Andreas Herrmann; Peter Scheurich; Klaus Pfizenmaier; Roland E Kontermann","Institut für Zellbiologie und Immunologie, Universität Stuttgart, Stuttgart, Germany; Celonic AG, Basel, Switzerland; Baliopharm AG, Basel, Switzerland","Conceived and designed the experiments: FR EG AH PS KP RK. Performed the experiments: FR TL. Analyzed the data: FR TL EG RK. Wrote the paper: FR EG AH PS KP RK.","AH, PS, KP, RK are named inventors of patents covering the Atrosab technology. AH is owner of Baliopharm, which is developing Atrosab for clinical use. EG is an employee of Balipharm, and TL is an employee of Celonic. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","08","Fabian Richter","FR",7,TRUE,6,2,4,6,TRUE,TRUE,FALSE,0,NA,FALSE
